Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology.
Fernandes
Susan M
SM
Boston Adult Congenital Heart Service, Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Newburger
Jane W
JW
Lang
Peter
P
Pearson
Dorothy D
DD
Feinstein
Jeffrey A
JA
Gauvreau
Kimberlee
K
Landzberg
Michael J
MJ
D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004541:Eisenmenger Complex / Q000175:diagnosis* / Q000188:drug therapy*; D004562:Electrocardiography; D011464:Epoprostenol / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006334:Heart Function Tests; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D012189:Retrospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome
D011464:Epoprostenol